Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Top Cited Papers
Open Access
- 7 October 2004
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 351 (15) , 1521-1531
- https://doi.org/10.1056/nejmoa033364
Abstract
The effectiveness of antiviral therapy in preventing disease progression in patients with chronic hepatitis B and advanced fibrosis or cirrhosis is unknown.Keywords
This publication has 34 references indexed in Scilit:
- Long–Term Suppression of Hepatitis B E Antigen–Negative Chronic Hepatitis B by 24–Month Interferon TherapyHepatology, 2003
- Management of Patients with Decompensated HBV CirrhosisSeminars in Liver Disease, 2003
- Chronic Hepatitis B and Hepatocarcinogenesis: Does Prevention of “Collateral Damage” Bring the Cure?Hepatology, 2003
- Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis BHepatology, 2002
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapyHepatology, 1999
- The Design and Analysis of Sequential Clinical Trials.Published by JSTOR ,1997
- Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter studyJournal of Hepatology, 1994
- Natural history and prognostic factors for chronic hepatitis type B.Gut, 1991
- Natural course after the development of cirrhosis in patients with chronic type B hepatitis: a prospective studyLiver International, 1989